Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Arranz

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Brain monoaminergic and neuropeptidergic variations in human agingB Arranz, K Blennow, R Ekman, et al.
Journal of Substance Abuse Treatment|September 29, 1998
Monitoring patterns of substance use in drug-dependent patientsL San, M Torrens, J Tato, et al.
International Journal of Clinical & Laboratory Research|January 1, 1997
Routine detection of point mutations in non-classic steroid 21-hydroxylaseI Machuca, L Ibañez, M R Bonnín, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 16, 2006
A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patientsL San, B Arranz, I Querejeta, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|October 21, 1999
Platelet serotonergic binding sites in alcohol-dependent patientsB Arranz, P Rosel, S Sarró, et al.
Recenti Progressi in Medicina|December 1, 1992
Salivary testosterone as an index of antiandrogen therapy in hirsutismJ M Gómez, M A Navarro, B Arranz, et al.
Journal of Affective Disorders|September 3, 2002
Loss of the circadian variation of platelet [3H]imipramine binding in delusional compared with non-delusional endogenously depressed patientsJ Vallejo, P Rosel, B Arranz, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1997
High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brainsP Rosel, B Arranz, J Vallejo, et al.
Journal of Affective Disorders|June 5, 1999
Altered [3H]imipramine and 5-HT2 but not [3H]paroxetine binding sites in platelets from depressed patientsP Rosel, B Arranz, J Vallejo, et al.
Human Psychopharmacology|December 28, 2006
Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patientsB Arranz, L San, R M Dueñas, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Brain monoaminergic and neuropeptidergic variations in human agingB Arranz, K Blennow, R Ekman, et al.
Journal of Substance Abuse Treatment|September 29, 1998
Monitoring patterns of substance use in drug-dependent patientsL San, M Torrens, J Tato, et al.
International Journal of Clinical & Laboratory Research|January 1, 1997
Routine detection of point mutations in non-classic steroid 21-hydroxylaseI Machuca, L Ibañez, M R Bonnín, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 16, 2006
A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patientsL San, B Arranz, I Querejeta, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|October 21, 1999
Platelet serotonergic binding sites in alcohol-dependent patientsB Arranz, P Rosel, S Sarró, et al.
Recenti Progressi in Medicina|December 1, 1992
Salivary testosterone as an index of antiandrogen therapy in hirsutismJ M Gómez, M A Navarro, B Arranz, et al.
Journal of Affective Disorders|September 3, 2002
Loss of the circadian variation of platelet [3H]imipramine binding in delusional compared with non-delusional endogenously depressed patientsJ Vallejo, P Rosel, B Arranz, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1997
High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brainsP Rosel, B Arranz, J Vallejo, et al.
Journal of Affective Disorders|June 5, 1999
Altered [3H]imipramine and 5-HT2 but not [3H]paroxetine binding sites in platelets from depressed patientsP Rosel, B Arranz, J Vallejo, et al.
Human Psychopharmacology|December 28, 2006
Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patientsB Arranz, L San, R M Dueñas, et al.
Pageof 5